3-(4-Fluoro-phenylsulfanylmethyl)-piperidine hydrochloride, 95.0%, 100mg

6-oxo-1,6-dihydropyrimidine-5-carboxamide, 95%, 250mg

fmoc-b-Homoaspartic acid (otbu), 95.0%, 250mg

2-Bromo-1-(tetrahydro-2H-pyran-4-yl)ethanone, 95.0%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 2, 100 µl, 1710 RN, 1 piece

2-Fluoro-3-isopropoxy-5-methylphenylboronic acid, 97%, 10g

tert-Butyl (oxiran-2-ylmethyl)carbamate, 98%, 1g

3-Bromo-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 250mg

1-Benzhydryl-3-methyleneazetidine, 95.0%, 10g

3-(Chloromethyl)-1,2,4-oxadiazole, 97.0%, 5g

2-Hydroxy-5-nitro-3-(trifluoromethyl)pyridine, 98.0%, 500g

6-Fluorooxindole, 99.0%, 1g

Bi granules 99.999% 1-10mm 250 g